Konstanze Doehner

2.1k total citations
14 papers, 101 citations indexed

About

Konstanze Doehner is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Konstanze Doehner has authored 14 papers receiving a total of 101 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 5 papers in Genetics and 3 papers in Molecular Biology. Recurrent topics in Konstanze Doehner's work include Acute Myeloid Leukemia Research (6 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Konstanze Doehner is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Konstanze Doehner collaborates with scholars based in Germany, Italy and Austria. Konstanze Doehner's co-authors include Hartmut Doehner, Richard F. Schlenk, Julia Bausinger, Helmut Hofemeister, Hans Jörg Fehling, Giuseppe Leone, Francesco D’Alò, Michaela Feuring‐Buske, A. Francis Stewart and Francesco Guidi and has published in prestigious journals such as New England Journal of Medicine, Blood and Cell stem cell.

In The Last Decade

Konstanze Doehner

13 papers receiving 100 citations

Peers

Konstanze Doehner
Kalyan Nadiminti United States
Courteney K. Lai Germany
Kathleen Stabla Germany
Samuel Pevzner United States
Aron Skaftason Sweden
Nikolaus Jahn Germany
Olena O Shevchuk Canada
Emil Hermansen Denmark
Stephanie Nance United States
Sofia Bakogianni United States
Kalyan Nadiminti United States
Konstanze Doehner
Citations per year, relative to Konstanze Doehner Konstanze Doehner (= 1×) peers Kalyan Nadiminti

Countries citing papers authored by Konstanze Doehner

Since Specialization
Citations

This map shows the geographic impact of Konstanze Doehner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Konstanze Doehner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Konstanze Doehner more than expected).

Fields of papers citing papers by Konstanze Doehner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Konstanze Doehner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Konstanze Doehner. The network helps show where Konstanze Doehner may publish in the future.

Co-authorship network of co-authors of Konstanze Doehner

This figure shows the co-authorship network connecting the top 25 collaborators of Konstanze Doehner. A scholar is included among the top collaborators of Konstanze Doehner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Konstanze Doehner. Konstanze Doehner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Radpour, Ramin, Carla A. Jaeger-Ruckstuhl, Gabriela M. Baerlocher, et al.. (2023). IL-33–ST2 signaling promotes stemness in subtypes of myeloid leukemia cells through the Wnt and Notch pathways. Science Signaling. 16(800). eadd7705–eadd7705. 10 indexed citations
2.
Stegelmann, Frank, Martin Grießhammer, Markus Bangerter, et al.. (2017). COMBINATION THERAPY OF POMALIDOMIDE PLUS RUXOLITINIB IN MYELOFIBROSIS: RESULTS FROM COHORT 1 OF THE MPNSG-0212 TRIAL (NCT01644110). Haematologica. 102. 280–280. 2 indexed citations
3.
Tasdogan, Alpaslan, Julia Bausinger, Helmut Hofemeister, et al.. (2016). DNA Damage-Induced HSPC Malfunction Depends on ROS Accumulation Downstream of IFN-1 Signaling and Bid Mobilization. Cell stem cell. 19(6). 752–767. 41 indexed citations
4.
Kent, David G., Christina A. Ortmann, Yvonne Silber, et al.. (2013). Order Matters: Sequence Of Mutation Acquisition In Myeloproliferative Neoplasms Impacts Disease Pathogenesis and Stem Cell Potency. Blood. 122(21). 2888–2888. 1 indexed citations
5.
Schittenhelm, Marcus M., Hartmut Doehner, Konstanze Doehner, et al.. (2012). Efficacy Analysis of the Novel Dual PI3K-MTORC1/2 Inhibitors NVP-BGT226 and NVP-BEZ235 in Acute Leukemia.. Blood. 120(21). 2474–2474. 1 indexed citations
6.
Langer, Christian, Mariam Ibáñez, Peter Liebisch, et al.. (2010). IDH1 and IDH2 mutations are Not Frequent In Multiple Myeloma. Blood. 116(21). 4992–4992. 4 indexed citations
7.
Kampa-Schittenhelm, Kerstin Maria, Mohit Trikha, Richard F. Schlenk, et al.. (2010). AC220, a Potent Second Generation Class I/III Tyrosine Kinase Inhibitor, Displays a Distinct Inhibition Profile on Mutant-FLT3 as Well as -KIT Isoforms. Blood. 116(21). 291–291. 1 indexed citations
8.
Seeringer, Angela, et al.. (2009). 9242 Pharmacogenetic factors in metabolism, transport and toxicity of cytarabine treatment in patients with AML. European Journal of Cancer Supplements. 7(2). 572–573. 3 indexed citations
9.
10.
Schlenk, Richard F., Konstanze Doehner, & Hartmut Döhner. (2008). Cytogenetically normal acute myeloid leukemia - Reply. New England Journal of Medicine. 359(6). 652–653. 1 indexed citations
11.
Voso, Maria Teresa, Stefan Hohaus, Francesco Guidi, et al.. (2008). Prognostic role of glutathione S-transferase polymorphisms in acute myeloid leukemia. Leukemia. 22(9). 1685–1691. 32 indexed citations
12.
Struve, Sabine, Guido Finazzi, Konstanze Doehner, et al.. (2008). Pregnancies in Patients with Philadelphia Negative Chronic Myeloproliferative Disorders: Interim Report of the European LeukemiaNet Data Base. Blood. 112(11). 2806–2806. 1 indexed citations
13.
Gaidzik, Verena I., Richard F. Schlenk, Annegret Becker, et al.. (2008). RUNX1 Mutations in Acute Myeloid Leukemia (AML): Correlation with Distinct Cytogenetic Subgroups and Clinical Outcome. Results of the AML Study Group (AMLSG). Blood. 112(11). 145–145. 2 indexed citations
14.
Schlenk, Richard F., Konstanze Doehner, Frank Hartmann, et al.. (2005). All-Trans Retinoic Acid and Gemtuzumab Ozogamicin as Adjunct To Salvage Therapy in Primary Refractory Acute Myeloid Leukemia: Results of Consecutive Phase II Studies of the AMLSG.. Blood. 106(11). 1849–1849. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kalyan Nadiminti Breakdown of academic impact, for papers by Courteney K. Lai Breakdown of academic impact, for papers by Kathleen Stabla Breakdown of academic impact, for papers by Samuel Pevzner Breakdown of academic impact, for papers by Aron Skaftason Breakdown of academic impact, for papers by Nikolaus Jahn Breakdown of academic impact, for papers by Olena O Shevchuk Breakdown of academic impact, for papers by Emil Hermansen Breakdown of academic impact, for papers by Stephanie Nance Breakdown of academic impact, for papers by Sofia Bakogianni
Rankless by CCL
2026